Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)

NCT00935090 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.

NCT NCT00935090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00935090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
Lead sponsor
Barbara Ann Karmanos Cancer Institute
Phase
Not reported
Overall status
Active, not recruiting
Start date
September 30, 2009
Completion date
April 4, 2027
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, chronic myeloproliferative disorders, leukemia, lymphoma, lymphoproliferative disorder, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, unspecified adult solid tumor, protocol specific